ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
CCR7 |
P32248
|
C-C motif chemokine receptor 7
|
G-protein coupled receptor
|
5.8E-02 |
0.443 |
0.769 |
CD14 |
P08571
|
CD14 molecule
|
|
4.9E-05 |
0.392 |
0.885 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CSF2 |
P04141
|
colony stimulating factor 2
|
Signaling
|
0.83 |
0.330 |
0.962 |
CSF3R |
Q99062
|
colony stimulating factor 3 receptor
|
Signaling
|
1.5E-10 |
0.550 |
0.692 |
DDX41 |
Q9UJV9
|
DEAD-box helicase 41
|
|
5.6E-08 |
0.636 |
0.538 |
DLL1 |
O00548
|
delta like canonical Notch ligand 1
|
|
1.00 |
0.492 |
0.808 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
EZH2 |
Q15910
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
Epigenetic regulator
|
1.00 |
0.376 |
0.885 |
FANCB |
Q8NB91
|
FA complementation group B
|
|
1.00 |
0.468 |
0.769 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
IL18 |
Q14116
|
interleukin 18
|
|
3.1E-02 |
0.365 |
0.923 |
IL3 |
P08700
|
interleukin 3
|
|
2.6E-09 |
0.489 |
0.731 |
JAK2 |
O60674
|
Janus kinase 2
|
Kinase
|
0.65 |
0.385 |
0.885 |
KIT |
P10721
|
KIT proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.98 |
0.366 |
0.808 |
KITLG |
P21583
|
KIT ligand
|
|
0.85 |
0.473 |
0.885 |